www.easy-to-use-pharmacy.com
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Stop Smoking
- Surgery
- Urinary Tract
- Women's Health
Generic Lamivudine - Combivir, Epivir
Generic Combivir
Lamivudine - Zidovudine 150mg + 300mg
Generic Combivir is in a group of medicines called reverse transcriptase inhibitors. It is used for treating HIV infection in combination with other medicines.
$1.44
Buy now!
Generic Epivir
Generic Epivir is used for treating HIV infection in combination with other medicines.
$1.73
Buy now!
Choose Your language:
- Testimonials
-
I have used viagra before and tried your generic brand and is the same. Except yours cost a lot less. Am very happy and will buy again From softcock to hardcock in 20 minutes what can be better than that ! - thank you chris
Read more »
-
- Aurobindo Pharma receives final approval for Lamivudine+Zidovudine Tablets - Equity Bulls
- Moneycontrol
- HIV positive patients face bleak future - NewsDay
- HIV positive patients face bleak futureNewsDayZimbabwe started phasing out the combination anti-retroviral treatment (ARV) Stavudine, Lamivudine and Nevirapine as its first-line option for the national programme, replacing it with the less toxic Tenofovir and Zidovudine-based regimens
- Lupin Launches Generic Combivir Tablets - RTT News
- Moneycontrol
- Lupin, Aurobindo get USFDA nod for HIV drug - Economic Times
- Lupin, Aurobindo get USFDA nod for HIV drugEconomic TimesLupin Pharmaceuticals Inc, a subsidiary of Lupin Ltd, has received final approval from US Food and Drug Administration (USFDA) for its generic Lamivudine and Zidovudine combination tablet in strength of 150mg/300 mg, Lupin said in a statement
- LANDMARK HIV DRUG'S PATENT EXPIRES TODAY - U-T San Diego
- LANDMARK HIV DRUG'S PATENT EXPIRES TODAYU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
